Pitt Shield

Acoustic Attenuation: Multifrequency Measurement and Relationship to CT and MR Imaging.

Authors: Webb TD, Leung SA, Ghanouni P, Dahl JJ, Pelc NJ, Pauly KB

Transcranial magnetic resonance-guided focused ultrasound (tcMRgFUS) is gaining significant acceptance as a noninvasive treatment for motion disorders and shows promise for novel applications such as blood-brain barrier opening for tumor treatment. A typical procedure relies on CT-derived acoustic property maps to simulate the transfer of ultrasound through the skull. Accurate estimates of the acoustic attenuation in the skull are essential to accurate simulations, but there is no consensus about how attenuation should be estimated from CT images and there is interest in exploring MR as a predictor of attenuation in the skull. In this study, we measure the acoustic attenuation at 0.5, 1, and 2.25 MHz in 89 samples taken from two ex vivo human skulls. CT scans acquired with a variety of X-ray energies, reconstruction kernels, and reconstruction algorithms, and MR images acquired with ultrashort and zero echo time sequences are used to estimate the average Hounsfield unit value, MR magnitude, and T2<sup>*</sup> value in each sample. The measurements are used to develop a model of attenuation as a function of frequency and each individual imaging parameter.

Introduction

Purpose Other
Study Objective To develop models predicting skull acoustic attenuation as a function of frequency and CT/MR imaging parameters by measuring attenuation in ex-vivo human skull samples.
Disease model healthy
MRI or image guidance method Transcranial magnetic resonance-guided focused ultrasound (tcMRgFUS)

Outcomes and Safety

Summary of Outcomes Skull acoustic attenuation across 0.5–2.25 MHz depends on frequency and correlates with CT Hounsfield units and UTE/ZTE MR measures (magnitude and T2*), enabling predictive models for tcMRgFUS simulations.
Duration of biological effect Not reported
Safety-related matter The provided text does not mention any safety concerns or adverse effects.

Brain Region

Visualization unavailable

Ultrasound Parameters

Ultrasound instrument none.
FUS Frequency 0.5 MHz, 1 MHz, 2.25 MHz
FUS Intensity Not reported in provided text
FUS Pressure Not reported
FUS Mode not reported
Pulse duration not reported
Duration of a single FUS session Not reported in the provided text
Focal Characteristics Not reported in the provided text
Treatment frequency single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search